JAK inhibition decreases the autoimmune burden in Down syndrome.
Rachubinski AL, Wallace E, Gurnee E, Enriquez-Estrada BA, Worek KR, Smith KP, Araya P, Waugh KA, Granrath RE, Britton E, Lyford HR, Donovan MG, Eduthan NP, Hill AA, Martin B, Sullivan KD, Patel L, Fidler DJ, Galbraith MD, Dunnick CA, Norris DA, Espinosa JM.
Rachubinski AL, et al. Among authors: smith kp.
Elife. 2024 Dec 31;13:RP99323. doi: 10.7554/eLife.99323.
Elife. 2024.
PMID: 39737640
Free article.
Clinical Trial.